Study of d-MAPPS™ Ophthalmic Solution, Safety, Tolerability, and Efficacy in the Treatment of Chronic Ocular Graft-Versus-Host Disease (oGVHD)

NCT06852768 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

1

Enrollment

INDUSTRY

Sponsor class

Conditions

oGHVD

Interventions

BIOLOGICAL: d-MAPPS
BIOLOGICAL: Placebo
OTHER: PI and Patient Masked

Sponsor

Regenerative Ocular Immunobiologics LLC